Scientists discover Alzheimer's risk gene

Image
Press Trust of India Los Angeles
Last Updated : Mar 07 2013 | 4:00 PM IST
Scientists including one of Indian-origin have discovered a common abnormality in the genetic code that increases the risk of Alzheimer's disease.
Scientists at the University of California, Los Angeles found a new genetic risk factor for Alzheimer's disease by screening people's DNA and then using an advanced type of scan to visualise their brains' connections.
To find the gene, they used a new imaging method that screens the brain's connections - the wiring, or circuitry, that communicates information.
Switching off such Alzheimer's risk genes (nine of them have been implicated over the last 20 years) could stop the disorder in its tracks or delay its onset by many years.
"We found a change in our genetic code that boosts our risk for Alzheimer's disease," said the study's senior author, Paul Thompson.
"If you have this variant in your DNA, your brain connections are weaker. As you get older, faulty brain connections increase your risk of dementia," he said in a statement.
The researchers including Neda Jahanshad, Priya Rajagopalan, Xue Hua, Derrek P Hibar, Talia M Nir and Arthur W Toga screened more than a thousand people's DNA to find the common "spelling errors" in the genetic code that might heighten their risk for the disease later in life.
The study was the first of its kind to also give each person a "connectome scan", a special type of scan that measures water diffusion in the brain, allowing scientists to map the strength of the brain's connections.
The new scan reveals the brain's circuitry and how information is routed around the brain, in order to discover risk factors for disease.
The researchers then combined these connectivity scans with the extensive genomic screening to pinpoint what causes faulty wiring in the brain.
In people whose genetic code differed in one specific gene called SPON1, weaker connections were found between brain centers controlling reasoning and emotion.
The rogue gene also affects how senile plaques build up in the brain - one of the hallmarks of Alzheimer's disease.
It has also been found that the SPON1 gene can be manipulated to develop new treatments for the devastating disease, Thompson noted.
When the rogue gene was altered in mice, it led to cognitive improvements and fewer plaques building up in the brain.
The study was published in the journal Proceedings of the National Academy of Sciences.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 07 2013 | 4:00 PM IST

Next Story